- Home
- RLI vs ELAN Comparison
RLI vs ELAN Comparison
Compare RLI & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLI
- ELAN
- Stock Information
- Founded
- RLI 1965
- ELAN 1954
- Country
- RLI United States
- ELAN United States
- Employees
- RLI N/A
- ELAN N/A
- Industry
- RLI Property-Casualty Insurers
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- RLI Finance
- ELAN Health Care
- Exchange
- RLI Nasdaq
- ELAN Nasdaq
- Market Cap
- RLI 7.2B
- ELAN 6.3B
- IPO Year
- RLI 1985
- ELAN 2018
- Fundamental
- Price
- RLI $174.71
- ELAN $13.97
- Analyst Decision
- RLI Buy
- ELAN Buy
- Analyst Count
- RLI 8
- ELAN 6
- Target Price
- RLI $173.67
- ELAN $17.00
- AVG Volume (30 Days)
- RLI 171.4K
- ELAN 4.5M
- Earning Date
- RLI 10-21-2024
- ELAN 11-07-2024
- Dividend Yield
- RLI 0.33%
- ELAN N/A
- EPS Growth
- RLI 45.44
- ELAN N/A
- EPS
- RLI 9.09
- ELAN 0.41
- Revenue
- RLI $1,764,783,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- RLI N/A
- ELAN $2.22
- Revenue Next Year
- RLI $6.57
- ELAN $2.77
- P/E Ratio
- RLI $19.24
- ELAN $33.88
- Revenue Growth
- RLI 22.63
- ELAN 1.99
- 52 Week Low
- RLI $125.77
- ELAN $11.40
- 52 Week High
- RLI $177.79
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- RLI 72.37
- ELAN 56.31
- Support Level
- RLI $165.59
- ELAN $12.35
- Resistance Level
- RLI $177.79
- ELAN $14.71
- Average True Range (ATR)
- RLI 2.38
- ELAN 0.49
- MACD
- RLI 1.45
- ELAN 0.19
- Stochastic Oscillator
- RLI 86.52
- ELAN 67.29
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.